熱門資訊> 正文

Neurogene定价1.25亿美元股权发行

2026-07-01 19:19

Neurogene Inc.(NGNE) 0

Neurogene (NGNE) priced a public offering of 3.5M common shares at $30.00 per share and 666,666 pre-funded warrants in lieu of common stock for certain investors.
The pre-funded warrants are exercisable immediately at a price of $0.000001 per share. The offering is expected to raise about $125M in gross proceeds before expenses and is scheduled to close on July 2, 2026, subject to customary closing conditions.
The company also granted the underwriters a 30-day option to purchase up to an additional 624,999 shares to cover overallotments.

More on Neurogene

Neurogene Inc. (NGNE) Discusses Updated Phase 1/2 Data for NGN-401 Gene Therapy in Rett Syndrome - Slideshow
Neurogene Inc. (NGNE) Discusses Updated Phase 1/2 Data for NGN-401 Gene Therapy in Rett Syndrome Transcript
Neurogene launches public stock offering
Seeking Alpha’s Quant Rating on Neurogene
Historical earnings data for Neurogene

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。